Global Rare Disease Organization Operating Model Design and Implementation Support

A global pharmaceutical had been working to enhance its capabilities in rare diseases. The company wanted to position its global rare disease (RD) franchise for growth by developing a new operating model that would improve decision-making, optimize the patient experience, and maximize commercial performance in preparation for upcoming US launches.

Our project had 3 key stages. During stage 1, our team gathered information critical to developing the vision and operating model. We conducted internal and external benchmarking to understand current challenges, articulate long-term goals, and identify implications for the new model, including gaps or shortfalls to be addressed in the next phase. During stage 2, our team further developed the operating model by refining goals, roles and responsibilities, and collaboration pathways for franchise teams, the global core team, and company leaders. The 3rd and final phase involved implementation, which included a detailed transition plan of action, as well as a series of leader prep sessions to help them get set up for success.

As a result of our work, the global RD franchise was equipped with a strategically solid vision and the organization design and operating model to make that vision a reality. With our team’s support, they successfully implemented the new operating model.